Business Context and Reporting Period
Aimei Health Technology Co., Ltd. (AFJK) is a Cayman Islands exempted company and a "blank check" SPAC formed to pursue a business combination with healthcare innovation targets. The reporting period covers the quarter and six months ended June 30, 2025. The Company has not commenced operations and generates no operating revenue; its activities are limited to formation, IPO costs, and pursuing a merger.
On June 19, 2024, the Company entered into a definitive Business Combination Agreement with United Hydrogen Group Inc. As of June 30, 2025, the Company has extended its deadline to consummate a business combination nine times, with the current deadline set for September 6, 2025.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 |
|---|---|---|
| Net Income | $609,632 | $1,364,592 |
| Operating Costs | ($455,018) | ($462,746) |
| Interest Income (Trust Account) | $1,064,650 | $1,827,338 |
| Cash (Operating) | $2,138 | $157,505 |
| Cash in Trust Account | $44,511,399 | $73,784,549 |
| Total Assets | $44,556,037 | $73,814,933 |
| Total Liabilities | $2,903,966 | $1,506,994 |
| Working Capital Deficit | ($2,169,328) | N/A |
| Extension Loans (Related Party) | $1,205,400 | $227,700 |
Material Changes vs. Prior Period
- Share Redemptions: On February 5, 2025, approximately 2,904,267 shares were redeemed at ~$10.77 per share, totaling ~$31.27 million. This significantly reduced the Trust Account balance from $73.8 million (Dec 31, 2024) to $44.5 million (June 30, 2025).
- Extension Fees: To extend the combination deadline, the Company incurred related-party extension loans. The balance increased from $227,700 to $1,205,400. The fee structure changed from a per-share basis to a flat $150,000 per month starting February 2025.
- Net Income Decline: Net income for the six months ended June 30, 2025, decreased by approximately 55% compared to the prior year period, primarily due to lower interest income earned on the reduced Trust Account balance.
- Liquidity: Operating cash dropped to $2,138, indicating a reliance on related-party funding for ongoing operations.
Outlook, Risks, and Management Commentary
- Going Concern: Management has identified substantial doubt about the Company's ability to continue as a going concern if a business combination is not consummated by September 6, 2025. In such an event, the Company must liquidate and dissolve.
- Merger Status: The Company is actively pursuing the merger with United Hydrogen. The Merger Agreement allows for termination if conditions are not met by September 30, 2025, or if shareholder approval is not obtained.
- Capital Needs: The Company has a working capital deficit. While no working capital loans were outstanding as of June 30, 2025, the Sponsor and affiliates may provide additional loans to finance transaction costs.
- Controls and Procedures: Management concluded that disclosure controls and procedures were not effective as of June 30, 2025.
- Deferred Fees: A deferred underwriting fee of $690,000 remains payable upon the closing of a business combination.
Investor Verification Checklist
- Merger Timeline: Verify the status of the United Hydrogen merger and the likelihood of closing before the September 6, 2025 deadline.
- Liquidity Runway: Confirm the Company's ability to fund operations with only $2,138 in operating cash and assess the commitment of related parties to fund further extensions.
- Redemption Risk: Monitor for additional shareholder redemptions which could further deplete the Trust Account and jeopardize the transaction.
- Related Party Debt: Review the terms of the $1.2 million in extension loans and the potential for conversion into equity or repayment upon liquidation.
- Internal Controls: Investigate the specific deficiencies leading to the conclusion that disclosure controls were ineffective.